OptiNose
OPTN
OPTN was delisted on the 20th of May, 2025.
65 hedge funds and large institutions have $72.7M invested in OptiNose in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 20 reducing their positions, and 23 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 20
0.23% less ownership
Funds ownership: 5.05% → 4.81% (-0.23%)
23% less funds holding
Funds holding: 84 → 65 (-19)
36% less capital invested
Capital invested by funds: $114M → $72.7M (-$41.7M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
83% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.25M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$912K |
| 3 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$720K |
| 4 |
JGC
J. Goldman & Co
New York
|
+$656K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$504K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$4.37M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$842K |
| 3 |
BC
BIT Capital
Berlin,
Germany
|
-$649K |
| 4 |
Millennium Management
New York
|
-$434K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$374K |
OPTN Hedge Fund Activity: Q3 2024 in Review
65 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q3 2024, worth a combined $72.7M — down 36% from $114M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of OPTN and 4 opened new positions — a net loss of 19 holders — while 20 trimmed existing stakes and 20 added.
The largest buyer was Stonepine Capital Management, adding an estimated $3.25M. The largest seller was BlackRock, cutting an estimated $4.37M.
- 65 institutional investors held OptiNose (OPTN) as of Q3 2024, down from 84 in Q2 2024.
- Funds reported $72.7M of OptiNose stock for Q3 2024, down 36% quarter-over-quarter.
- 4 funds opened new OptiNose positions in Q3 2024 and 23 closed out, a net change of -19 holders.
- The largest OptiNose buyer in Q3 2024 was Stonepine Capital Management, an estimated $3.25M added.
- The largest OptiNose seller in Q3 2024 was BlackRock, an estimated $4.37M sold.
Based on aggregated 13F filings for Q3 2024.